AstraZeneca Sued By University For Crestor Patent Infringement

esilverman Just a few short months after settling patent challenges to its all-important Crestor cholesterol-lowering pill, AstraZeneca is now facing a fresh lawsuit in which ...

Medicines Patent Pool Strikes Yet Another Big Pharma Deal

esilverman In the latest victory for the Medicines Patent Pool, Roche has agreed to improve access to Valcyte, which his used to treat cytomegalovirus, or CMV, a viral infection ...

India pulls another patent, this time for GSK’s Tykerb

Eric Palmer India's Intellectual Property Appellate Board (IPAB) has pulled the patent that GlaxoSmithKline had for its breast cancer drug Tykerb, a salt form of lapatinib, while ...

‘Brazil generics issue’ costs Sanofi nearly as much as patent losses

Eric Palmer Because Sanofi has been investing heavily in emerging markets in recent years to help it offset revenue declines from patent expirations, a 2.3%  crash in sales in ...

Naurex Announces Issuance of New Patent for Novel Antidepressant Glyx-13

barbara.lempert —Extends Patent Life to 2030 for Novel Agent that Demonstrated Rapid Onset, Robust Efficacy and Good Safety in a Phase II Trial—   EVANSTON, IL – July 30, ...

FTC eyeing new patent deals for pay-for-delay action

Tracy Staton Emboldened by the U.S. Supreme Court ruling on "pay-for-delay" patent settlements, the Federal Trade Commission is looking for opportunities to sue drugmakers ...

Lilly freezes salaries ahead of patent loss for Cymbalta

Eric Palmer Eli Lilly's CEO John Lechleiter was out for a couple of months as he dealt with some heart issues. He recently returned and guess what he brought with him? More bad ...

GPhA President and CEO Comments on Patent Settlements

mia.burns Statement from Ralph G Neas President And Ceo of the Generic Pharmaceutical Association on the Pirg Community Catalyst Report on Patent Settlements WASHINGTON, July 11 — ...

Actavis Confirms Generic Vimpat Patent Challenge

mia.burns PARSIPPANY, N.J., July 12, 2013 /PRNewswire/ — Actavis, Inc. (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. ...

GPhA: Patent settlements saved system $25.5B

Eric Palmer The Federal Trade Commission and some consumer groups would like Congress to make pay-for-delay deals illegal. But the Generic Pharmaceutical Association has ...

Aegis Awarded Patent for Transdermal or Transmucosal Absorption Enhancement for Peptide and Small Molecule Drugs

barbara.lempert SAN DIEGO, CA July 8, 2013/MarketWire– Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,470,370 providing proprietary methods ...

Apogenix Strengthens Patent Position for Apocept (APG101) in Europe and Canada

barbara.lempert Heidelberg, Germany, July 2, 2013 – Apogenix GmbH, a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS